ArticlePloS one2025

Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO study): Protocol of a double-blind randomized controlled clinical trial.

Konstantinos Bitos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.